MetLife secures last-minute Real Value of $48.1925 per share. The latest price of the firm is $39.76. At this time the firm appears to be under valued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Current Valuation of 114.15B, Profit Margin of
7.89% and Return On Equity of 9.90% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
MetLife Market CapMetLife is regarded second in market capitalization category among related companies. Market capitalization of Insurance - Life industry is now estimated at about 172.24 Billion. MetLife totals roughly 39 Billion in market capitalization claiming about 23% of equities under Insurance - Life industry.
|Horizon||30 Days Login to change|
MetLife is regarded fifth in beta category among related companies. It is rated below average in price to book category among related companies fabricating about 0.64 of Price to Book per Beta. The ratio of Beta to Price to Book for MetLife is roughly 1.57
|Price to Book ( times )|
December 18, 2018
MetLife is not too volatile asset. Calculation of real value of MetLife is based on 2 months time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
|Enterprise Value To Ebitda||17.03|
|Enterprise Value To Revenue||1.68|